Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Johan Grooten
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
18
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor
01 January 2015 → 31 December 2018
Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
Funding: European funding: framework programme
01 October 2009 → 26 February 2015
Airway-specific activation of Liver X Receptor for the treatment of Mycobacterium tuberculosis infection
Fellow: Muriel Smet
Funding: Regional and community funding: IWT/VLAIO
01 January 2014 → 31 August 2016
Designing novel particulate vaccination strategies to evoke cytotoxic T cell responses against chronic intracellular infections
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 01 October 2012
Development and evaluation of particulate formulations for the selective delivery of antigens and immunpotentiators towards dendritic cells.
Funding: Regional and community funding: Special Research Fund
01 January 2008 → 30 December 2013
Differentiation of COX-2-dependent and -independent VEGF induction in mouse tumors and human colorectal carcinoma and its association with malignancy and sensitivity to anti-angiogenic therapy
Funding: Research Foundation - Flanders (FWO)
01 January 2009 → 31 December 2014
Disease-modifying characteristics of LXR-dependent signaling pathways in infectious and non-infectious inflammatory lung diseases
Funding: Research Foundation - Flanders (FWO)
01 December 2012 → 30 November 2016
Increasing the efficiency of RNA-cancer vaccination by modulation of type-I-IFN activity, and interference with PD-LI / PD-1 to the tumor bed
Fellow: Ans De Beuckelaer
Funding: Regional and community funding: IWT/VLAIO
01 January 2012 → 31 October 2016
Novel molecular intervention technology for infectious and allergic respiratory diseases
Funding: Regional and community funding: Special Research Fund
01 January 2010 → 01 May 2010
Novel mouse models of allergic broncho-pulmonary disease as effective drug-testing tools to treat severe noneosinophilic asthma (type 3)
Funding: Regional and community funding: IWT/VLAIO
01 November 2010 → 31 October 2015
Role of the mycobacterial cell wall lipids, myocolic acids, in the control of ontracellular replication of mycobacterium tuberculasis bacilli
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2011
Signal transduction in inflammation: from gene to organism
Funding: Federal funding: various
01 October 2008 → 30 September 2011
Synthetic mycolic acid as potential therapeutic agents for the treatment of asthma
Funding: Funding by bilateral agreement (private and foundations)
15 June 2008 → 14 June 2009
Synthetic mycolic acids for therapy of asthma and as adjuvants for vaccination
Funding: Regional and community funding: Industrial Research Fund
02 July 2013 → 31 May 2015
Targeting the modified innate functionality of the post-asthma alveolar macrophage for relieving Respiratory Syncytical Virus-induced astham exacerbation.
Funding: Funding by bilateral agreement (private and foundations)
01 January 2014 → 31 December 2019
Towards a universal mRNA-based therapeutic vaccine against HIV
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 January 2007 → 31 October 2013
Epithelial breast cancer: from molecular signaling pathways to clinical application
Funding: Regional and community funding: Special Research Fund
01 January 2010 → 31 December 2015
In vivo transduction of dendritic cells with mRNA for the development of an immunotherapy
Funding: Research Foundation - Flanders (FWO)
01 January 2009 → 31 December 2012
Novel macrophage and myeloid dendritic cell markers for in vivo imaging and therapy of inflammatory diseases; Inflammation tracking "Inflammatrack"
Funding: Regional and community funding: various